drugset / Trial / NCT06543667
Limbal Stem Cell Derived Exosome (LSC-Exo) Eye Drop for Treatment of Dry Eye
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the safety and efficacy of Limbal Stem Cells derived Exosomes (LSC-Exo) in alleviation of dry eye symptoms
Timeline
- Start
- 2024-08-01
- Primary completion
- 2026-01-01
- Completion
- 2026-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Limbal Stem Cell Derived Exosomes | Other / unclassified | 10 ug | Topical |
| Subject | Limbal Stem Cell Derived Exosomes | Other / unclassified | 0.15 ml | Topical |